Article
Pharmacogenetics of drug‐induced liver injury†
19 Apr 2010
Abstract excerpt
Recent progress in research on drug-induced liver injury (DILI) has been determined by key developments in two areas. First, new technologies allow the identification of genetic risk factors with improved sensitivity, specificity, and efficiency. Second, new mechanistic concepts of DILI emphasize the importance of unspecific "downstream" events following drug-specific initial "upstream" hepatocyte injury and of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
